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Abstract – Croatia is a country that, despite the »war« epidemic of opiate
addiction, has continuously had a very low incidence of the disease and the
proportion of seropositive iv. opiate addicts is very low and has shown a sta-
ble trend (0.5% in 2009 and 2010). N.N. (30) was raised in an urban dys-
functional family. He has been an intravenous heroin addict since he was
16. Before hospital admission, he was on maintenance therapy with metha-
done. HIV and hepatitis C infection were diagnosed one year ago. The pa-
tient was referred for hospital treatment due to the indicated transfer to
buprenorphine therapy. When applying the transfer from high methadone
doses to buprenorphine there is a risk of severe withdrawal syndrome. In
order to ensure and facilitate the transfer, a standardized method was devel-
oped at the Department: it shortens the time and reduces the transfer risk
from high methadone doses to buprenorphine. The transfer from metha-
done to buprenorphine is indicated in HIV – positive opiate addicts because
of significantly less adverse drug interactions in the case of antiviral ther-
apy implementation.
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EPIDEMIOLOGY
Epidemiological data point to the fact that from 1985 to 2010 out of 862 registered
persons diagnosed with HIV infection in Croatia, 325 developed AIDS. The annual
number of new AIDS cases is still less than 4 per million in the total population.1
Therefore, Croatia is a country that, despite the »war« epidemic of opiate addiction,
has continuously had a very low incidence of the disease and the proportion of sero-
positive iv. opiate addicts is very low and has shown a stable trend (0.5% in
2006-2011; HCV 40.5%, HBV 7.3% in 2011 –less than previous years). The low per-
centage of infected intravenous drug users is mostly due to good medical treatment of
addicts and other prevention measures implemented continuously since 1986.2,5
ANAMNESIS
N.N. (30) was raised in an urban dysfunctional family. He had a liberal education,
and the mother abused alcohol. From early adolescence he has manifested behavioral
problems and experimented with different drugs. He has been an intravenous heroin
addict since he was 16, and he has been coming to the Centre for treatment and pre-
vention of addiction since 2000, without achieving significant periods of abstinence
from opiates. Before hospital admission, he was on maintenance therapy with metha-
done, with a daily dose of 100 mg.
He is inclined to promiscuous behavior and is convinced that his girlfriend infected
him with HIV by sharing the injecting equipment and having unprotected sex. Ayear
ago HIV infection and hepatitis C were discovered after testing at the Centre for treat-
ment and addiction prevention.
TRANSFER FROM METHADONE TO BUPRENORPHINE
The patient was referred for hospital treatment from an authorized Centre for pre-
vention and treatment of addiction due to the indicated transfer to buprenorphine
therapy. When applying the transfer from high methadone doses to buprenorphine,
there is a risk of severe withdrawal syndrome, which can consequently lead to the
abandoning of the treatment process. In order to ensure and facilitate the transfer, a
standardized method was developed at the Department: it shortens the time and re-
duces the transfer risk from high methadone doses to buprenorphine.3 Therefore, on
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the first day of hospital admission, we discontinued the use of methadone and pre-
vented the withdrawal syndrome by introducing SR morphine sulfate, 200% higher
daily those than methadone dose. After one week and after achieving the elimination
of methadone from his body, the transfer to buprenorphine was carried out without
difficulties, with a daily dose of 16 mg.3
CHOICE OF SUBSTITUTION THERAPY
The transfer from methadone to buprenorphine is indicated in HIV – positive opi-
ate addicts because of significantly less adverse drug interactions in the case of antivi-
ral therapy implementation. Most antiviral drugs are inducers of methadone metabo-
lism and therefore may produce withdrawal symptoms that may necessitate dose
increases of methadone (e.g. abacavir, amprenavir, lopinavir, darunavir, nevirapin).
Other antiviral drugs (e.g. atazanavir, delavirdin, indinavir) inhibit methadone me-
tabolism and may cause the serum increase of methadone levels which has been
linked to QT interval prolongation and cardiac arrhythmia.
Concomitant use of methadone can result in reduction of antivirals in serum and
loss of efficiency (didanosin, stavudin, atazanavir) or may inhibit metabolism of
antivirals such as zidovudine and increase their serum levels. Amantadine and
tenofovir appears to be well tolerated in methadone maintained patients. Most antivi-
ral drugs are well tolerated in combination with buprenorphine. Also buprenorphine
maintenance treatment may improve adherence to highly active antiviral therapy.
Clinically non significant QT prolongation has been detected in combination with
delavirdine and ritonavir. An increase of buprenorphine serum levels is detected in
combination with atazanavir, delavirdin, saquinavir and indinavir.4
CONCLUSION
When the substitution therapy with opiate agonists is indicated in the treatment of
the opiate addiction, buprenorphine is a therapy of choice in HIV positive opiate ad-
dicts at the time of antiviral therapy implementation.
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IZBOR SUBSTITUCIJSKE TERAPIJE U HIV POZITIVNOG OPIJATSKOG
OVISNIKA
Sa`etak – Unato~ porastu broja novootkrivenih slu~ajeva HIV infekcije te porasta broja
novooboljelih od AIDS-a u svijetu, Hrvatska je s ukupno 862 registrirane osobe s HIV in-
fekcijom i godi{njim brojem novooboljelih od AIDS-a manjim od 4 na milijun stanovnika jo{
uvijek zemlja s vrlo niskom razinom u~estalosti te bolesti. Podaci o rezultatima testiranja na
hepatitis B, C i HIV u Hrvatskoj ukazuju da je udio HIV seropozitivnih opijatskih ovisnika ve}
du`i niz godina niskih vrijednosti i stabilnog trenda. Nizak postotak zara`enih intravenskih
ovisnika virusom HIV-a mo`emo zahvaliti kvalitetnom radu sustava za medicinsko lije~enje
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ovisnika. Pacijent N.N. je upu}en na bolni~ko lije~enje iz jednog Centra za prevenciju i
lije~enje ovisnosti radi indiciranog transfera s metadonske na buprenorfinsku terapiju. Radi
lak{eg transfera, standardiziranom metodom, pacijentu je ukinuta metadonska terapija i do
eliminacije metadona uvedena terapija morfij-sulfatom, po ~emu je postupak proveden uredno
do stabilizacije uz buprenorfinsku terapiju. Transfer sa metadonske na buprenorfinsku terapiju
je izrazito bitan kod HIV pozitivnih pacijenata zbog interakcija lijekova i boljih rezultata
lije~enja prilikom provo|enja antivirusne terapije u HIV pozitivnih opijatskih ovisnika.
Klju~ne rije~i: antivirusna terapija, supstitucijska terapija buprenorfinom, HIV pozitivni
opijatski ovisnici.
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